Acta Pharmacologica Sinica, 40(10), 12901298
Regulatory treatment of GLP-1 support foods varies significantly between markets, creating complexity for companies operating internationally: EU/UK Explicit references to GLP-1 are not permitted, and weight management claims remain tightly controlled within specific regulated categories such as meal replacements Japan/Brazil Limited GLP-1 claims may be possible via specialist/health channels
At 3 and 6 months, HbA 1c , body weight and estimated glomerular filtration rate should be assessed, and any other medications that have been discontinued or reduced should be re-evaluated
Here are the main ones: For Weight Loss: Wegovy (semaglutide) Zepbound (tirzepatide) Saxenda (liraglutide) For Diabetes (sometimes used for weight loss): Ozempic (semaglutide) Mounjaro (tirzepatide) Trulicity (dulaglutide) Victoza (liraglutide) Rybelsus (oral semaglutide) Most GLP-1 medications come as shots you give yourself once a week
Key Effects: Improves sleep quality and depth Reduces time to fall asleep Decreases stress and anxiety Supports circadian rhythm balance Enhances recovery and regeneration Increases energy and endurance Supports nervous system function Mild analgesic effect Benefits: Needle-free convenient nasal spray Fast-acting formula High bioavailability Suitable for regular use Compact 10 ml bottle Composition: DSIP (Delta Sleep-Inducing Peptide) 5 mg Directions for Use: Apply 14 sprays 3040 minutes before sleep
Robert SA, Rohana AG, Shah SA, Chinna K, Wan WN, Mohamud, Kamaruddin NA (2015) Improvement in binge-eating in non-diabetic obese individuals after 3 months of treatment with liraglutidea pilot study